View Item 

Show simple item record

Immunosuppression: Evolution in Practice and Trends, 1994–2004

dc.contributor.authorMeier-Kriesche, Herwig-Ulfen_US
dc.contributor.authorLi, S.en_US
dc.contributor.authorGruessner, R. W. G.en_US
dc.contributor.authorFung, J. J.en_US
dc.contributor.authorBustami, Rami T.en_US
dc.contributor.authorBarr, M. L.en_US
dc.contributor.authorLeichtman, Alan B.en_US
dc.date.accessioned2010-06-01T20:48:44Z
dc.date.available2010-06-01T20:48:44Z
dc.date.issued2006-05en_US
dc.identifier.citationMeier-Kriesche, H.-U.; Li, S.; Gruessner, R. W. G.; Fung, J. J.; Bustami, R. T.; Barr, M. L.; Leichtman, A. B. (2006). "Immunosuppression: Evolution in Practice and Trends, 1994–2004." American Journal of Transplantation 6(5p2): 1111-1131. <http://hdl.handle.net/2027.42/73911>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73911
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16613591&dopt=citationen_US
dc.format.extent205358 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2006 The American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherAcute Rejectionen_US
dc.subject.otherImmunosuppressionen_US
dc.subject.otherInduction Therapyen_US
dc.subject.otherMaintenance Immunosuppressionen_US
dc.subject.otherSRTRen_US
dc.subject.otherTransplantationen_US
dc.titleImmunosuppression: Evolution in Practice and Trends, 1994–2004en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumScientific Registry of Transplant Recipients, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherUniversity of Florida, Gainesville, FL, USAen_US
dc.contributor.affiliationotherScientific Registry of Transplant Recipients, University Renal Research and Education Association, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherUniversity of Minnesota, Minneapolis, MN, USAen_US
dc.contributor.affiliationotherCleveland Clinic, Cleveland, OH, USAen_US
dc.contributor.affiliationotherUniversity of Southern California, Los Angeles, CA, USAen_US
dc.identifier.pmid16613591en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73911/1/j.1600-6143.2006.01270.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2006.01270.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceLevine GN, McCullough KP, Rodgers AM, Dickinson DM, Ashby VB, Schaubel DE. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6 ( Part 2 ): 1228 – 1242.en_US
dc.identifier.citedreferenceGruessner RWG. Immunobiology, diagnosis, and treatment of pancreas graft rejection. In: Gruessner RWG, Sutherland DE, eds. Transplantation of the Pancreas. New York: Springer-Verlag, 2004: 349 – 380.en_US
dc.identifier.citedreferenceGruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433 – 455.en_US
dc.identifier.citedreferenceGruessner RW, Kandaswamy R, Humar A, Gruessner AC, Sutherland DE. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation 2005; 79: 1184 – 1189.en_US
dc.identifier.citedreferenceEason JD, Nair S, Cohen AJ, Blazek JL, Loss GE, Jr. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation 2003; 75: 1396 – 1399.en_US
dc.identifier.citedreferenceRaimondo ML, Burroughs AK. Single-agent immunosuppression after liver transplantation: What is possible? Drugs 2002; 62: 1587 – 1597.en_US
dc.identifier.citedreferenceMarcos A, Eghtesad B, Fung JJ et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus. Transplantation 2004; 78: 966 – 971.en_US
dc.identifier.citedreferenceBucuvalas JC, Zeng L, Anand R. Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl 2004; 10: 1011 – 1017.en_US
dc.identifier.citedreferenceWiesner RH, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Lake JR. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl 2005; 11: 750 – 759.en_US
dc.identifier.citedreferenceNeyts J, Meerbach A, McKenna P, De Clercq E. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections. Antiviral Res 1996; 30: 125 – 132.en_US
dc.identifier.citedreferenceFirpi RJ, Nelson DR, Davis GL. Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection. Liver Transpl 2003; 9: 57 – 61.en_US
dc.identifier.citedreferenceFasola CG, Heffron TG, Sher L et al. Multicenter randomized hepatitis C (HCV) three trial post liver transplantation (OLT): A one-year follow up report (abstract). Am J Transplant 2005; 5 ( Suppl 11 ): 276.en_US
dc.identifier.citedreferenceJain A, Kashyap R, Dodson F et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: A single center report. Transplantation 2001; 72: 1091 – 1097.en_US
dc.identifier.citedreferenceMele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000; 47: 215 – 245.en_US
dc.identifier.citedreferenceNair S, Eason J, Loss G. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transpl 2003; 9: 126 – 129.en_US
dc.identifier.citedreferenceShapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: Evolution in practice and trends, 1993–2003. Am J Transplant 2005; 5 ( 4 Pt 2 ): 874 – 886.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2006.01270.x.pdf
Size:
200.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.